Valuation: Procter & Gamble Health Limited

Market Cap 91.35B 978M 892M 824M 744M 1.4B 1.46B 9.96B 3.94B 49.31B 3.67B 3.59B 156B P/E 2027 *
24.9x
P/E 2028 * 22.3x
Enterprise Value 91.35B 978M 892M 824M 744M 1.4B 1.46B 9.96B 3.94B 49.31B 3.67B 3.59B 156B EV / Sales 2027 *
5.9x
EV / Sales 2028 * 5.24x
Free-Float
47.79%
Yield 2027 *
1.98%
Yield 2028 * 2.15%
1 day+0.57%
1 week-4.67%
Current month-2.63%
1 month+8.04%
3 months-4.24%
6 months+3.52%
Current year-2.92%
1 week 5,372.7
Extreme 5372.7
5,856.25
1 month 4,728.3
Extreme 4728.3
6,000
Current year 4,699.7
Extreme 4699.7
6,955
1 year 4,699.7
Extreme 4699.7
6,955
3 years 4,640.3
Extreme 4640.3
6,955
5 years 3,883
Extreme 3883
6,955
10 years 860
Extreme 860
7,499.95
Manager TitleAgeSince
Chief Executive Officer 57 01/04/2018
Director of Finance/CFO - 01/10/2025
Chief Tech/Sci/R&D Officer - 01/09/2025
Director TitleAgeSince
Director/Board Member 57 01/04/2018
Director/Board Member 51 01/06/2019
Chairman 70 01/04/2025
Change 5-day change 1-year change 3-year change Capi.($)
+0.57%-4.67%-5.83%+7.09% 978M
-2.32%-3.79%+34.24%+133.69% 1,232B
-2.15%-2.75%+36.35%+82.05% 656B
-2.33%-3.04%+22.29%+106.80% 506B
-0.93%-1.67%+28.85%+68.54% 382B
-3.90%-6.39%+42.88%+35.41% 340B
-2.79%-4.78%+25.02%+51.64% 294B
-1.25%-3.15%-0.77%+33.50% 278B
-3.07%-5.17%+29.04%+67.26% 240B
-0.75%-0.44%+32.87%+123.96% 210B
Average -1.09%-2.58%+24.50%+70.99% 414B
Weighted average by Cap. -1.13%-2.67%+29.94%+91.19%

Financials

2027 *2028 *
Net sales 15.47B 166M 151M 140M 126M 237M 247M 1.69B 667M 8.35B 621M 608M 26.37B 17.43B 187M 170M 157M 142M 267M 278M 1.9B 751M 9.41B 700M 685M 29.71B
Net income 3.67B 39.29M 35.83M 33.13M 29.9M 56.31M 58.53M 400M 158M 1.98B 147M 144M 6.26B 4.09B 43.74M 39.89M 36.88M 33.28M 62.68M 65.15M 445M 176M 2.21B 164M 161M 6.97B
Net Debt - -
Projected Income Statement - Annual - Procter & Gamble Health Limited
Logo Procter & Gamble Health Limited
Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.
Employees
1,276
Date Price Change Volume
19/11/26 ₹5,534.70 +0.57% 209
18/11/26 ₹5,503.25 +0.57% 357
17/11/26 ₹5,472.05 -2.28% 280
16/11/26 ₹5,599.85 -3.84% 297
13/11/26 ₹5,823.70 +0.30% 167
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
MarketScreener Ratings - Procter & Gamble Health Limited

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Procter & Gamble Health Limited
  1. Stock Market
  2. Stocks
  3. PGHL Stock